STOCK TITAN

Bon Natural Life Ltd - BON STOCK NEWS

Welcome to our dedicated news page for Bon Natural Life (Ticker: BON), a resource for investors and traders seeking the latest updates and insights on Bon Natural Life.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bon Natural Life's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bon Natural Life's position in the market.

Rhea-AI Summary
Bon Natural Life Limited (Nasdaq: BON) has achieved a significant breakthrough in apple polyphenol extraction technology, which is expected to drive considerable growth in the company's apple polyphenol products in the upcoming fiscal year. This development comes after ten years of R&D efforts to solve quality stability issues and reduce production costs. With an annual production capacity of 300 to 500 tons, the company anticipates significant progress in sales, positioning apple polyphenol as a key driver for sustainable growth and shareholder value enhancement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.5%
Tags
-
Rhea-AI Summary
Bon Natural Life Limited (Nasdaq: BON) has entered into a sales distributing contract with Beijing Huahai Keyuan Technology Co. Ltd. for its broccoli products in the Chinese market with a total product value of US$45 million. The recent broccoli product, Broclife®, utilizes broccoli seed extract as the core active ingredient and offers various health benefits. The partnership with Huahai and the exceptional Broclife® product are expected to boost sales and profit growth, enhancing the company's investment value and generating greater returns for shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.89%
Tags
none
-
Rhea-AI Summary
Bon Natural Life Limited (Nasdaq: BON) has announced a breakthrough in converting glucoraphanin into sulforaphane, an active ingredient in broccoli extract. The company's R&D team has developed a new compound system that enhances the transformation rate and bioavailability of broccoli extract, reduces production costs, and extends the shelf life of extract products. BON plans to launch health supplement products under the trademark Broclife® in areas of sleep improvement, digestive health, and immune health. The CEO, Yongwei Hu, anticipates substantial growth and aims to reach a projected market of tens of millions of dollars over the next three years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.33%
Tags
none
Rhea-AI Summary
Bon Natural Life signs MOU with Jiangwang for distribution of Chinese White Spirits and health products in China markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
none
-
Rhea-AI Summary
Bon Natural Life Limited announces 1H-2023 financial results with a 3.4% increase in total revenue and a decrease in net income. Fragrance compounds revenue decreased by 8.4%, health supplements revenue increased by 37.2%, and bioactive food ingredients revenue decreased by 5.2%. Gross profit increased for fragrance compounds and health supplements but decreased for bioactive food ingredients. General and administrative expenses increased by 46.8% and R&D expenses decreased by 21.1%. Net income decreased and net cash used in operating activities increased. Diluted EPS was $0.24.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.38%
Tags
none
-
Rhea-AI Summary
Bon Natural Life Limited (Nasdaq: BON) received a letter from Nasdaq stating that due to resignations from the Board of Directors, the company no longer complies with Nasdaq's requirements. The company has until August 14, 2023, to submit a plan to regain compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.21%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.14%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.08%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.96%
Tags
management
Bon Natural Life Ltd

Nasdaq:BON

BON Rankings

BON Stock Data

4.96M
964.47k
18.74%
0.51%
0.3%
Medicinal and Botanical Manufacturing
Manufacturing
Link
China
Xi'an

About BON

bon natural life was founded in 2006, is engaged in the research and development, production, and sales of plant extracts in china. dedicated to functional food, personal care and other fields to provide plant active ingredients and compound product solutions.<br> the company is headquartered in xi'an high-tech zone, shaanxi province, china with independent research and development center and testing laboratory, with two production bases in weinan and tongchuan, a new production base in yumen, gansu province under construction, marketing network coverage at home and abroad.bon has obtained production and operation license, iso9001 quality management system certification, iso22000 food safety management system certification, fda inspection certification, kosher, halal and other certifications. in the field of plant extracts, the production and sales of bon meet the relevant national standards and requirements.<br> as a high-tech enterprise driven by technology, bon has applied for